| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/02/1992 | US5118625 Autonomously replicating plasmid and saccharomycopsis lipolytica transformed therewith |
| 06/02/1992 | US5118623 Alkaline proteases useful in detergent can be used in pesence of hypochlorite for stain removal |
| 06/02/1992 | US5118620 Transforming antibiotic sensitive prokaryotic or eukaryotic cell with an expression vector to confer antibiotic resistance |
| 06/02/1992 | US5118617 Saf polypeptide, gene coding therefor, saf promoter and expression methods for expressing foreign dna sequences in streptomyces |
| 06/02/1992 | US5118616 Method of producing substances in living silkworms |
| 06/02/1992 | US5118615 Gene insertion to an expression vector; hypotensive and diuretic |
| 06/02/1992 | US5118605 Polynucleotide determination with selectable cleavage sites |
| 06/02/1992 | US5118603 Heating with peroxy compounds |
| 06/02/1992 | CA1302652C Method for purifying granulocyte-macrophage colony stimulating factor |
| 06/02/1992 | CA1302322C DNA STRAND CODING FOR .alpha.-ACETOLACTATE DECARBOXYLASE AND YEAST TRANSFORMED WITH THE DNA STRAND |
| 06/02/1992 | CA1302320C Expression of human cromosomal interferon-_ in animal cells |
| 05/31/1992 | WO1992010760A1 Methods for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | WO1992009631A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2097426A1 Method for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | CA2097309A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2056661A1 Protein and preparation thereof |
| 05/31/1992 | CA2056564A1 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 05/31/1992 | CA2056261A1 Antibody reactive to hamster immunoglobulins |
| 05/30/1992 | CA2056646A1 Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents |
| 05/29/1992 | WO1992008807A1 Preparation of nucleic acid samples |
| 05/29/1992 | WO1992008802A1 Bispecific antibodies, method of production, and uses thereof |
| 05/29/1992 | WO1992008798A1 Expression of genes in transgenic plants |
| 05/29/1992 | WO1992008797A1 Heterologous gene expression system |
| 05/29/1992 | WO1992008789A1 Measles virus recombinant poxvirus vaccine |
| 05/29/1992 | WO1992008788A1 Mutant orientable proteins and coated substrates |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008738A1 Monoclonal antibodies to hepatitis c virus and method for using same |
| 05/29/1992 | WO1992008737A1 NEW HUMAN RECOMBINANT η INTERFERON |
| 05/29/1992 | WO1992008735A1 Novel cytokine |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008486A1 Avirulent microbes and uses therefor: salmonella typhi |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992006199A3 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/29/1992 | CA2056326A1 Enzymic process for the synthesis of ammonium adipate |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/27/1992 | WO1992009633A1 Immunoglobulin-binding proteins and recombinant dna molecules coding therefor |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487333A2 Process for producing L-tryptophan and L-threonine |
| 05/27/1992 | EP0487301A1 Method of stabilizing enzyme conjugates |
| 05/27/1992 | EP0487298A2 Human gamma interferon antagonist/agonist screen |
| 05/27/1992 | EP0487229A1 A DNA encoding a protein which binds to the enhancer of alpha-fetoprotein gene |
| 05/27/1992 | EP0487218A1 Method for detecting or quantifying target nucleic acid |
| 05/27/1992 | EP0487159A1 A food-grade vector suitable for transforming a food-grade host cell, use of said vector for transforming food-grade host cells, and use of said transformed cells in biotransformation processes |
| 05/27/1992 | EP0487118A1 Transformation selection marker system adapted for Penicillium |
| 05/27/1992 | EP0487116A1 Biologically active PDGF analogs in eucaryotic cells |
| 05/27/1992 | EP0487099A2 Bacteriorhodopsine - double mutants |
| 05/27/1992 | EP0487028A2 Apparatus for extracting and purifying nucleic acid |
| 05/27/1992 | EP0486917A2 Antiviral activity from the rep gene of adenoassociated virus-2 |
| 05/27/1992 | EP0486908A2 TNF-Muteins |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486861A1 Active fragments of fibroblast growth factor |
| 05/27/1992 | EP0486683A1 Production of cyclodextrins in transgenic plants |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486627A1 Trypanosoma cruzi recombinant antigens and synthetic peptides for utilization inthe immunological diagnosis of chagas disease |
| 05/27/1992 | EP0486619A1 Method of screening for protein inhibitors and activators |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486562A1 Mutant pseudorabies virus, and vaccines containing the same |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | EP0486495A1 Expression system for actinomycetes and related organisms |
| 05/27/1992 | EP0334904B1 Process for inactivating recombinant dna |
| 05/27/1992 | DE4036855C1 Plasmid DNA (DSM-6237) and expression vectors - encoding human gamma interferon prodn., prepd. by cleavage of c-DNA |
| 05/27/1992 | CN1016796B Process of producing useful substances |
| 05/27/1992 | CN1016795B Production of hemopoietin |
| 05/27/1992 | CA2096953A1 Immunoglobulin-binding proteins and recombinant dna molecules coding therefor |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | US5116750 Genetic engineering DNA technology |
| 05/26/1992 | US5116746 Hydrolysis; genetic engineering |
| 05/26/1992 | US5116744 Microbial cyanide converting enzymes, their production and use |
| 05/26/1992 | US5116742 RNA ribozyme restriction endoribonucleases and methods |
| 05/26/1992 | US5116739 Process for the production of human apolipoprotein e, and transformed hosts and products thereof |
| 05/26/1992 | CA1301679C Process of producing highly transformable cells and cells produced thereby |
| 05/26/1992 | CA1301678C Promoter, vector having the improved promoter, plasmid having the vector, and transformer with the plasmid |
| 05/26/1992 | CA1301677C Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them |
| 05/26/1992 | CA1301676C Genetic expression of somatostatin as hybrid polypeptide |
| 05/26/1992 | CA1301675C Polycistronic expression vector construction |
| 05/26/1992 | CA1301674C Pseudorabies virus recombinants and their use in the production of proteins |
| 05/26/1992 | CA1301672C Amplification method for polynucleotide assays |
| 05/24/1992 | CA2056056A1 Food-grade vector suitable for transforming a food-grade host cell, use of said vector for transforming food-grade host cells and use of said transformed cells in biotransformation processes |
| 05/24/1992 | CA2055961A1 Active fragments of fibroblast growth factor |
| 05/22/1992 | CA2055168A1 Tnf-muteins |
| 05/21/1992 | WO1992008729A1 Antisense nucleic acid derivative |
| 05/21/1992 | CA2096658A1 Anti-sense nucleic acid derivative |
| 05/21/1992 | CA2096633A1 Measles virus recombinant poxvirus vaccine |
| 05/21/1992 | CA2055812A1 Method of stabilizing enzyme conjugates |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486290A2 A method and composition for increasing the accumulation of squalene and specific sterols in yeast |
| 05/20/1992 | EP0486234A2 Plant transformation method using agrobacterium species |
| 05/20/1992 | EP0486233A2 Plant transformation method using agrobacterium species |
| 05/20/1992 | EP0486214A2 Putrescine N-methyltransferase, recombinant DNA molecules encoding putrescine N-methyltrasferase, and transgenic tobacco plants with altered nicotine content |
| 05/20/1992 | EP0486193A2 A method for altering post-translational processing of tissue plasminogen activator |
| 05/20/1992 | EP0486170A1 Baculoviral expression system comprising procaryotic leader sequence |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0486067A2 Peroxidase gene of microbial origin |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |